Show simple item record

dc.contributor.authorArai, Yuka
dc.date.accessioned2016-08-02T00:31:02Z
dc.date.available2016-08-02T00:31:02Z
dc.date.issued2011
dc.identifier.urihttp://hdl.handle.net/20.500.11803/348
dc.description.abstractPsychosomatic Medicine (PM) is increasingly practiced in the field of psychiatry and psychotherapy. Cognitive-Behavioural Therapy (CBT) and pharmacological treatment are widely used and have clinically proven their efficacy in PM. In this proposal, the efficacy of outpatient Morita Therapy (MT) is compared with CBT and pharmacological protocols as treatments for anxiety-related psychosomatic symptoms. The design is a randomized clinical trial with three levels of treatment: CBT, outpatient MT, and CBT with pharmacological treatment. Dependent measures include scales for both manifest anxiety and psychosomatic symptoms. Eligibility for subjects is based on diagnosable anxiety disorder with psychosomatic symptoms. The discussion focuses on the need for a wider range and more in-depth brief treatments for anxiety-related psychosomatic disorders.en_US
dc.language.isoenen_US
dc.subjectTreatment of psychosomatic symptomsen_US
dc.subjectMorita Therapy
dc.subjectTreatments for anxiety-related psychosomatic disorders
dc.subjectPsychosomatic disorders
dc.subject.lcshMedicine, Psychosomatic
dc.subject.lcshMorita psychotherapy
dc.subject.lcshAnxiety--Treatment
dc.titleOutpatient Morita Therapy and Anxiety Disorder with Somatic Symptoms in Western Populationen_US
dc.typeThesisen_US
thesis.degree.disciplineCounselingen_US
thesis.degree.grantorCity University of Seattleen_US
thesis.degree.levelMastersen_US
thesis.degree.nameMaster of Artsen_US
cityu.schoolDivision of Arts and Sciencesen_US
cityu.siteVancouver, BCen_US
cityu.site.countryCanadaen_US


Files in this item

Restricted

This item appears in the following Collection(s)

Show simple item record